261 related articles for article (PubMed ID: 10543761)
21. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
22. DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.
Memišević V; Kumar K; Zavaljevski N; DeShazer D; Wallqvist A; Reifman J
BMC Bioinformatics; 2016 Sep; 17():387. PubMed ID: 27650316
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
Nhung PH; Van VH; Anh NQ; Phuong DM
J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
[TBL] [Abstract][Full Text] [Related]
24. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei.
Anuntagool N; Sirisinha S
Microbiol Immunol; 2002; 46(3):143-50. PubMed ID: 12008922
[TBL] [Abstract][Full Text] [Related]
25. Drug screening to identify compounds to act as co-therapies for the treatment of Burkholderia species.
Barker S; Harding SV; Gray D; Richards MI; Atkins HS; Harmer NJ
PLoS One; 2021; 16(3):e0248119. PubMed ID: 33764972
[TBL] [Abstract][Full Text] [Related]
26. Evaluating New Compounds to Treat
Ross BN; Myers JN; Muruato LA; Tapia D; Torres AG
Front Cell Infect Microbiol; 2018; 8():210. PubMed ID: 30013953
[No Abstract] [Full Text] [Related]
27. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
[TBL] [Abstract][Full Text] [Related]
29. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
[TBL] [Abstract][Full Text] [Related]
30. Present and future therapeutic strategies for melioidosis and glanders.
Estes DM; Dow SW; Schweizer HP; Torres AG
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):325-38. PubMed ID: 20192686
[TBL] [Abstract][Full Text] [Related]
31. Development of a polymerase chain reaction assay for the specific identification of Burkholderia mallei and differentiation from Burkholderia pseudomallei and other closely related Burkholderiaceae.
Ulrich RL; Ulrich MP; Schell MA; Kim HS; DeShazer D
Diagn Microbiol Infect Dis; 2006 May; 55(1):37-45. PubMed ID: 16546342
[TBL] [Abstract][Full Text] [Related]
32. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
Lu DC; Chang SC; Chen YC; Luh KT; Hsieh WC
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):187-91. PubMed ID: 9327247
[TBL] [Abstract][Full Text] [Related]
33. Development of hydrolysis probe-based real-time PCR for identification of virulent gene targets of Burkholderia pseudomallei and B. mallei--a retrospective study on archival cases of service members with melioidosis and glanders.
Zhang B; Wear DJ; Kim HS; Weina P; Stojadinovic A; Izadjoo M
Mil Med; 2012 Feb; 177(2):216-21. PubMed ID: 22360070
[TBL] [Abstract][Full Text] [Related]
34. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials.
Karunakaran R; Puthucheary SD
Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912
[TBL] [Abstract][Full Text] [Related]
35. A conserved active site PenA β-lactamase Ambler motif specific for Burkholderia pseudomallei/B. mallei is likely responsible for intrinsic amoxicillin-clavulanic acid sensitivity and facilitates a simple diagnostic PCR assay for melioidosis.
Somprasong N; Hagen JP; Sahl JW; Webb JR; Hall CM; Currie BJ; Wagner DM; Keim P; Schweizer HP
Int J Antimicrob Agents; 2023 Mar; 61(3):106714. PubMed ID: 36640845
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J
ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514
[TBL] [Abstract][Full Text] [Related]
37. Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms.
Pibalpakdee P; Wongratanacheewin S; Taweechaisupapong S; Niumsup PR
Int J Antimicrob Agents; 2012 Apr; 39(4):356-9. PubMed ID: 22364716
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of sitafloxacin against Burkholderia pseudomallei.
Thamlikitkul V; Trakulsomboon S
Int J Antimicrob Agents; 2011 Oct; 38(4):364. PubMed ID: 21775108
[No Abstract] [Full Text] [Related]
39. Antimicrobial resistance in Burkholderia pseudomallei.
Vorachit M; Chongtrakool P; Arkomsean S; Boonsong S
Acta Trop; 2000 Feb; 74(2-3):139-44. PubMed ID: 10674642
[TBL] [Abstract][Full Text] [Related]
40. Molecular identification and typing of Burkholderia pseudomallei and Burkholderia mallei: when is enough enough?
Antonov VA; Tkachenko GA; Altukhova VV; Savchenko SS; Zinchenko OV; Viktorov DV; Zamaraev VS; Ilyukhin VI; Alekseev VV
Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S134-9. PubMed ID: 19121675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
